Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mélanie Gauthier

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
British Journal of Nursing (Mark Allen Publishing)|July 21, 2021
Innovative approaches to teaching vascular access to nursing students in the COVID-19 eraCaroline Marchionni, Madolyn Connolly, Mélanie Gauthier, et al.
Cancers|February 25, 2023
Systematic Review on CAR-T Cell Clinical Trials Up to 2022: Academic Center InputValentine Wang, Mélanie Gauthier, Véronique Decot, et al.
Critical Reviews in Oncology/Hematology|February 19, 2021
Natural Killer cells and monoclonal antibodies: Two partners for successful antibody dependent cytotoxicity against tumor cellsMélanie Gauthier, Caroline Laroye, Danièle Bensoussan, et al.
Journal of Clinical Medicine|December 19, 2019
Mesenchymal Stem/Stromal Cell Production Compliant with Good Manufacturing Practice: Comparison between Bone Marrow, the Gold Standard Adult Source, and Wharton's Jelly, an Extraembryonic SourceCaroline Laroye, Mélanie Gauthier, Hélène Antonot, et al.
Journal of Clinical Nursing|July 16, 2020
Nurses' knowledge on routine care and maintenance of adult vascular access devices: A scoping reviewAndrea Raynak, France Paquet, Caroline Marchionni, et al.
Bulletin Du Cancer|September 7, 2023
[Organizational and budgetary impacts of the implementation of CAR-T cell therapies in a French academic hospital]Lucas Fleta, Mélanie Gauthier, Pauline Lider, et al.
Annales Pharmaceutiques Francaises|March 1, 2025
[European pharmacovigilance of advanced therapy medicinal products]Nadine Petitpain, Viktoryia Prontskus, Mélanie Gauthier, et al.
Radiation Oncology (London, England)|November 6, 2016
Absolute volume of the rectum and AUC from rectal DVH between 25Gy and 50Gy predict acute gastrointestinal toxicity with IG-IMRT in prostate cancerCéline Mirjolet, Paul M Walker, Mélanie Gauthier, et al.
Radiation Oncology (London, England)|September 18, 2012
Exclusive image guided IMRT vs. radical prostatectomy followed by postoperative IMRT for localized prostate cancer: a matched-pair analysis based on risk-groupsCaroline Azelie, Mélanie Gauthier, Céline Mirjolet, et al.
Cancer|March 23, 2011
Second-line chemotherapy with fluorouracil, leucovorin, and irinotecan (FOLFIRI regimen) in patients with advanced small bowel adenocarcinoma after failure of first-line platinum-based chemotherapy: a multicenter AGEO studyAziz Zaanan, Mélanie Gauthier, David Malka, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
British Journal of Nursing (Mark Allen Publishing)|July 21, 2021
Innovative approaches to teaching vascular access to nursing students in the COVID-19 eraCaroline Marchionni, Madolyn Connolly, Mélanie Gauthier, et al.
Cancers|February 25, 2023
Systematic Review on CAR-T Cell Clinical Trials Up to 2022: Academic Center InputValentine Wang, Mélanie Gauthier, Véronique Decot, et al.
Critical Reviews in Oncology/Hematology|February 19, 2021
Natural Killer cells and monoclonal antibodies: Two partners for successful antibody dependent cytotoxicity against tumor cellsMélanie Gauthier, Caroline Laroye, Danièle Bensoussan, et al.
Journal of Clinical Medicine|December 19, 2019
Mesenchymal Stem/Stromal Cell Production Compliant with Good Manufacturing Practice: Comparison between Bone Marrow, the Gold Standard Adult Source, and Wharton's Jelly, an Extraembryonic SourceCaroline Laroye, Mélanie Gauthier, Hélène Antonot, et al.
Journal of Clinical Nursing|July 16, 2020
Nurses' knowledge on routine care and maintenance of adult vascular access devices: A scoping reviewAndrea Raynak, France Paquet, Caroline Marchionni, et al.
Bulletin Du Cancer|September 7, 2023
[Organizational and budgetary impacts of the implementation of CAR-T cell therapies in a French academic hospital]Lucas Fleta, Mélanie Gauthier, Pauline Lider, et al.
Annales Pharmaceutiques Francaises|March 1, 2025
[European pharmacovigilance of advanced therapy medicinal products]Nadine Petitpain, Viktoryia Prontskus, Mélanie Gauthier, et al.
Radiation Oncology (London, England)|November 6, 2016
Absolute volume of the rectum and AUC from rectal DVH between 25Gy and 50Gy predict acute gastrointestinal toxicity with IG-IMRT in prostate cancerCéline Mirjolet, Paul M Walker, Mélanie Gauthier, et al.
Radiation Oncology (London, England)|September 18, 2012
Exclusive image guided IMRT vs. radical prostatectomy followed by postoperative IMRT for localized prostate cancer: a matched-pair analysis based on risk-groupsCaroline Azelie, Mélanie Gauthier, Céline Mirjolet, et al.
Cancer|March 23, 2011
Second-line chemotherapy with fluorouracil, leucovorin, and irinotecan (FOLFIRI regimen) in patients with advanced small bowel adenocarcinoma after failure of first-line platinum-based chemotherapy: a multicenter AGEO studyAziz Zaanan, Mélanie Gauthier, David Malka, et al.
Pageof 3